RO60 and interstitial lung disease: The German Network for Systemic Sclerosis (reporting on 863 SSc patients) and the Canadian Scleroderma Research Group (963 patients) described an odds ratio for SSc-ILD of 2.20 and 2.86 respectively with anti-SSA/Ro60 positivity [113,114].